These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 8806127)

  • 21. [Dermatologic topical corticosteroids. Principles and usage standards, posology].
    Ann Dermatol Venereol; 2000 Oct; 127(Spec No 1):A180-5. PubMed ID: 11474520
    [No Abstract]   [Full Text] [Related]  

  • 22. Topical formulary for the pediatrician.
    Lester RS
    Pediatr Clin North Am; 1983 Aug; 30(4):749-65. PubMed ID: 6225068
    [No Abstract]   [Full Text] [Related]  

  • 23. The use of corticosteroids in dermatological practice.
    Barnetson RS; White AD
    Med J Aust; 1992 Mar; 156(6):428-31. PubMed ID: 1545752
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potency assessment of topical corticoids in the vasoconstrictor assay and on tuberculin-induced inflammation.
    Schalla W; Schorning S
    Skin Pharmacol; 1991; 4(3):191-204. PubMed ID: 1768431
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Topical use of systemic drugs in dermatology: a comprehensive review.
    Chiu HY; Tsai TF
    J Am Acad Dermatol; 2011 Nov; 65(5):1048.e1-22. PubMed ID: 21570151
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Guidelines of care for the use of topical glucocorticosteroids. American Academy of Dermatology.
    Drake LA; Dinehart SM; Farmer ER; Goltz RW; Graham GF; Hordinsky MK; Lewis CW; Pariser DM; Webster SB; Whitaker DC; Butler B; Lowery BJ; Raimer SA; Krafchik BR; Olsen E; Weston WL
    J Am Acad Dermatol; 1996 Oct; 35(4):615-9. PubMed ID: 8859293
    [No Abstract]   [Full Text] [Related]  

  • 27. Glucocorticoid action on skin collagen: overview on clinical significance and consequences.
    Nuutinen P; Autio P; Hurskainen T; Oikarinen A
    J Eur Acad Dermatol Venereol; 2001 Jul; 15(4):361-2. PubMed ID: 11730056
    [No Abstract]   [Full Text] [Related]  

  • 28. Topical corticosteroids in dermatology.
    Mehta AB; Nadkarni NJ; Patil SP; Godse KV; Gautam M; Agarwal S
    Indian J Dermatol Venereol Leprol; 2016; 82(4):371-8. PubMed ID: 27279294
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human test models for bioequivalence of topical corticosteroids: a review.
    Olsen EA
    Int J Dermatol; 1992 Oct; 31 Suppl 1():9-13. PubMed ID: 1428469
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Steroids in dermatology.
    Miller JA; Levene GM
    Br J Hosp Med; 1982 Oct; 28(4):331-2, 337-8. PubMed ID: 6291678
    [No Abstract]   [Full Text] [Related]  

  • 31. [The external treatment of dermatoses (author's transl)].
    Ormea F
    MMW Munch Med Wochenschr; 1974 Mar; 116(13):637-42. PubMed ID: 4212846
    [No Abstract]   [Full Text] [Related]  

  • 32. Topical steroids: a guide for use in the elderly patient.
    Pariser DM
    Geriatrics; 1991 Oct; 46(10):51-4, 57-60, 63. PubMed ID: 1916302
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Per-gram cost of medication is by itself a poor indicator for comparing costs of different psoriasis treatments: a retrospective cohort study of the cost of psoriasis treatment with topical corticosteroids versus topical calcipotriene.
    Feldman SR; Sahu S; Fleischer AB; Dezii CM
    J Cutan Med Surg; 2000 Jul; 4(3):121-5. PubMed ID: 11003715
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Topical corticosteroids usage in dermatology.
    Uppal R; Sharma SC; Bhowmik SR; Sharma PL; Kaur S
    Int J Clin Pharmacol Ther Toxicol; 1991 Feb; 29(2):48-50. PubMed ID: 2026463
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Glucocorticoids in the therapy of dermatologic diseases].
    Merk HF
    Med Monatsschr Pharm; 1989 Apr; 12(4):111-6. PubMed ID: 2657356
    [No Abstract]   [Full Text] [Related]  

  • 36. Topical application of calcipotriene and corticosteroids: combination regimens.
    Lebwohl M
    J Am Acad Dermatol; 1997 Sep; 37(3 Pt 2):S55-8. PubMed ID: 9344186
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Randomized, Double-Blind, Placebo-Controlled Study of the Vasoconstrictor Potency of Topical 0.25% Desoximetasone Spray: A High to Super High Range of Potency (Class I to Class II) Corticosteroid Formulation.
    Oussedik E; Saleem MD; Feldman SR
    J Drugs Dermatol; 2017 Oct; 16(10):972-975. PubMed ID: 29036250
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapy with topical corticosteroids.
    Sterry W
    Arch Dermatol Res; 1992; 284 Suppl 1():S27-9. PubMed ID: 1285653
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The potency, efficacy, and usage of superpotent topical corticosteroids.
    Parish LC; Witkowski JA; Millikan LE; Kamm AR
    Int J Dermatol; 1990 Dec; 29(10):709-10. PubMed ID: 2269564
    [No Abstract]   [Full Text] [Related]  

  • 40. Advances in topical therapy for skin diseases.
    Willsteed EM
    Med J Aust; 1996 Sep; 165(5):274-9. PubMed ID: 8816688
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.